Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - SCAPA GROUP PLC

13 Apr 2021 14:39

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)Full name of discloser:Barclays PLC.
 
(b)Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c)Name of offeror/offeree in relation to whoseSCAPA GROUP PLC
relevant securities this form relates:
(d)If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e)Date position held/dealing undertaken:12 April 2021
(f)In addition to the company in 1(c) above, is the discloser makingNO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:5p ordinary
InterestsShort Positions
Number(%)Number(%)

(1)

Relevant securities owned

 

 

 

 

and/or controlled:

3,672,743

1.95%

134,904

0.07%

 

 

 

 

(2)

Cash-settled derivatives:

 

 

 

 

117,391

0.06%

2,062,563

1.10%

 

 

 

 

(3)

Stock-settled derivatives (including options)

 

 

 

 

and agreements to purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

TOTAL:

3,790,134

2.02%

2,197,467

1.17%

 

 

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevantPurchase/saleNumber ofPrice per unit
securitysecurities

5p ordinary

Purchase

1,062

2.1500 GBP

5p ordinary

Purchase

3,408

2.1497 GBP

5p ordinary

Sale

4,466

2.1449 GBP

5p ordinary

Sale

13,920

2.1500 GBP

(b) Cash-settled derivative transactions

Class ofProductNature of dealingNumber ofPrice per
relevantdescriptionreferenceunit
securitysecurities

5p ordinary

SWAP

Long

4,466

2.1449 GBP

5p ordinary

CFD

Long

13,920

2.1498 GBP

5p ordinary

SWAP

Short

3,408

2.1497 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:13 Apr 2021
Contact name:Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210413005759/en/

Copyright Business Wire 2021

Date   Source Headline
2nd Jul 20184:33 pmRNSTotal Voting Rights
28th Jun 20184:12 pmRNSDirector/PDMR Shareholding
5th Jun 20184:00 pmRNSDirector/PDMR Shareholding
31st May 201810:31 amRNSTotal Voting Rights
30th May 201810:20 amRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSFinal Results
30th Apr 201810:30 amRNSTotal Voting Rights
12th Apr 20187:00 amRNSTrading Statement
11th Apr 20183:29 pmRNSIncident at Dunstable Site
29th Mar 201811:48 amRNSTotal Voting Rights
26th Mar 20187:00 amRNSAcquisition
28th Feb 20181:38 pmRNSTotal Voting Rights
7th Feb 20189:17 amRNSBlock listing Interim Review
31st Jan 20189:08 amRNSTotal Voting Rights
25th Jan 20182:14 pmRNSBlock listing Interim Review
8th Jan 201810:10 amRNSDirectorate Change
7th Dec 20173:52 pmRNSDirector/PDMR Shareholding
7th Dec 20173:49 pmRNSAdditional Listing
29th Nov 201711:15 amRNSDirector/PDMR Shareholding
28th Nov 20172:56 pmRNSDirector/PDMR Shareholding
28th Nov 20172:44 pmRNSDirector/PDMR Shareholding
23rd Nov 20179:36 amRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSHalf-year Report
17th Nov 201710:22 amRNSAdditional Listing
11th Oct 20177:00 amRNSTrading Statement
4th Oct 20177:00 amRNSCapital Markets Day
26th Sep 201711:38 amRNSAdditional Listing
21st Sep 20174:21 pmRNSHolding(s) in Company
8th Sep 201711:31 amRNSDirector/PDMR Shareholding
4th Sep 20173:18 pmRNSDirector/PDMR Shareholding
4th Sep 201710:13 amRNSAdditional Listing
25th Aug 20177:00 amRNSDirector/PDMR Shareholding
17th Aug 20174:14 pmRNSDirector/PDMR Shareholding
11th Aug 20174:12 pmRNSDirector/PDMR Shareholding
9th Aug 20177:00 amRNSAcquisition
7th Aug 20171:56 pmRNSBlock listing Interim Review
25th Jul 201710:09 amRNSBlock listing Interim Review
19th Jul 20179:29 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSAGM Statement
1st Jun 20171:59 pmRNSHolding(s) in Company
30th May 20172:09 pmRNSAdditional Listing
23rd May 20177:00 amRNSFinal Results
18th May 20173:47 pmRNSHolding(s) in Company
17th May 20173:36 pmRNSHolding(s) in Company
3rd May 201710:31 amRNSAdditional Listing
21st Apr 20179:41 amRNSHolding(s) in Company
19th Apr 20173:33 pmRNSAdditional Listing
13th Apr 20177:00 amRNSTrading Statement
27th Mar 20172:05 pmRNSDirector/PDMR Shareholding
23rd Mar 201711:46 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.